Sup. Figure 9: Foretinib treatment had no remarkable anti-angiogenic effect in the liver metastasis model or brain metastasis-mimicking model. from Foretinib Overcomes Entrectinib Resistance Associated with the &lt;i&gt;NTRK1&lt;/i&gt; G667C Mutation in &lt;i&gt;NTRK1&lt;/i&gt; Fusion–Positive Tumor Cells in a Brain Metastasis Model